العلاج في الخطوة التالية لداء الكيسات العصبي الحوصلي النخاعي القابل للحياة عند عدم حل الكيسات بالألبيندازول منفرداً

References

DOI: 10.1093/cid/cix1084

• In the absence of elevated intracranial pressure, we recommend use of antiparasitic drugs in all patients with VPN (strong, moderate).
• For patients with 1–2 viable parenchymal cysticerci, we recommend albendazole monotherapy for 10–14 days compared to either no antiparasitic therapy (strong, high) or combination antiparasitic therapy (weak, low).
• We suggest retreatment with antiparasitic therapy for parenchymal cystic lesions persisting for 6 months after the end of the initial course of therapy (weak, low).
• Options for retreatment include a second course of albendazole, switching to praziquantel, or using the combination of albendazole and praziquantel.